Xcout Intel
Imcheck Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Imcheck Therapeutics among biotechnology companies — ranked by similarity to what Imcheck Therapeutics actually does, not by market-cap band.
Subscribe to see Imcheck Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Imcheck Therapeutics
ImCheck Therapeutics designs and develops next-generation immunotherapeutic antibodies focused on modulating the immune system through the butyrophilin and butyrophilin-like superfamily of checkpoint molecules. The company's pipeline targets treatments for cancer, infectious disease, and autoimmune disease.
Imcheck Therapeutics at a glance
Imcheck Therapeutics is a biotechnology company headquartered in France. Xcout tracks 3 named people at Imcheck Therapeutics, including David Loew (CEO, Ipsen).
Imcheck Therapeutics leadership
- David LoewCEO, Ipsen
- Pierre d’EpenouxCEO, ImCheck Therapeutics
- Daniel OliveProf.
Top 12 Imcheck Therapeutics competitors
Ranked by semantic similarity — how close each company is to Imcheck Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Similar biotechnology company
ImmunOs Therapeutics AG is a biotechnology company that develops treatments for cancer and inflammatory diseases by harnessing the human immune system. The company focuses on immuno-oncology and autoimmune therapies through a dedicated drug pipeline.
Similar biotechnology company
ImmPACT Bio is a biotechnology company developing next-generation cancer immunotherapies, including dual-targeted CAR T-cell therapies. Its programs are intended to serve patients with B-cell malignancies and potentially other cancers, including solid tumors.
Similar biotechnology company
Matchpoint Therapeutics Inc. discovers and develops precision small molecule medicines utilizing covalent chemistry and chemoproteomics screening to treat immune diseases. The company leverages proprietary screening technologies and machine learning algorithms to expand the druggable proteome and design covalent drug candidates for patients with serious inflammatory and immune conditions.
Biotech
Inventisbio is a biopharmaceutical company that focuses on the discovery and development of innovative drugs for major diseases such as tumors, autoimmune diseases, and metabolic disorders. Utilizing an independent research and development platform, the company creates proprietary drug pipelines targeting oncology drivers, kinases, and autoimmune pathways to serve patients globally.
Similar biotechnology company
Monocacy Therapeutics Inc. develops artificial intelligence-guided, first-in-class immune medicines designed to restore optimal immune function and patient health. The company utilizes a full-stack, AI-powered immunology platform to discover and develop next-generation immunotherapies for patients.
Similar biotechnology company
Grey Wolf Therapeutics is a biotechnology company headquartered in the UK focused on delivering a new class of treatments to improve the lives of people with cancers and autoimmune disorders.
Similar biotechnology company
Indapta Therapeutics is a biotechnology company founded in 2017 that focuses on developing and commercializing proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer cell therapies for cancer and other immune-mediated diseases.
Similar biotechnology company
Blue Marlin Therapeutics is developing a non-viral, in vivo immune-cell engineering platform that combines targeted lipid nanoparticle delivery, genomic integration, and promoter-gated expression. The company aims to provide durable, cell-specific therapies for patients with oncology and autoimmune diseases.
Biotech
Electra Therapeutics is a biopharmaceutical company focused on developing first-in-class antibody therapies targeting signal regulatory proteins (SIRP) for immunological and oncological diseases.
Similar biotechnology company
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Imcheck Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Imcheck Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →